ALREFIMOTIDE

Investigational

Approval Year

Substance Class	Protein
Protein Type	VACCINE ANTIGEN
Protein Sub Type	T-CELL ANTIGEN
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	KN5EG8XV39
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

ALREFIMOTIDE

Official Name

English

P-719-20

Preferred Name

English

UV1 COMPONENT TELOMERASE REVERSE TRANSCRIPTASE 660-689 PEPTIDE ANTIGEN

Common Name

English

L-ALANINE, L-ALANYL-L-LEUCYL-L-PHENYLALANYL-L-SERYL-L-VALYL-L-LEUCYL-L-ASPARAGINYL-L-TYROSYL-L-.ALPHA.-GLUTAMYL-L-ARGINYL-L-ALANYL-L-ARGINYL-L-ARGINYL-L-PROLYLGLYCYL-L-LEUCYL-L-LEUCYLGLYCYL-L-ALANYL-L-SERYL-L-VALYL-L-LEUCYLGLYCYL-L-LEUCYL-L-.ALPHA.-ASPAR

Systematic Name

English

alrefimotide [INN]

Common Name

English

Showing 1 to 5 of 10 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

CAS

1331848-79-3

PRIMARY

SMS_ID

300000040832

PRIMARY

NCI_THESAURUS

C184841

PRIMARY

FDA UNII

KN5EG8XV39

PRIMARY

INN

11701

PRIMARY

Showing 1 to 5 of 5 entries

Previous1Next

Subunit 0

Show entries

Related Record

Type

Details


					O2SR7A38OP

ALREFIMOTIDE ACETATE

SALT/SOLVATE -> PARENT

Amount:


					NH2W5DQ1DO

TELOMERASE REVERSE TRANSCRIPTASE

TARGET->VACCINE ANTIGEN

Amount:

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Related Record

Type

Details


					KN5EG8XV39

ALREFIMOTIDE

ACTIVE MOIETY

Comments:

Used in Cancer immunotherapy

Amount:

Showing 1 to 1 of 1 entries

Previous1Next

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL	ESTIMATED C146H238O39N46
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL	ESTIMATED 3280 Da (average)

Showing 1 to 2 of 2 entries

Previous1Next